Clinical Trials Logo

Clinical Trial Summary

A long-term follow-up cohort study of patients that were assigned in two previous studies to compare the clinical results of sclerotherapy of telangiectasias and reticular veins of lower limbs using 0.2% polidocanol diluted in 70% hypertonic glucose (PDHG) vs 75% hypertonic glucose (HG) alone. All women, previously treated as aforementioned, were invited to be reevaluated regarding late maintenance and pigmentation over two years of follow-up. No new treatments were applied to the cohort.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05860439
Study type Observational
Source UPECLIN HC FM Botucatu Unesp
Contact
Status Completed
Phase
Start date January 1, 2017
Completion date June 1, 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT00406380 - Effect of Avastin in Juxtafoveal Telangiectasias Phase 3
Completed NCT00005392 - Epidemiology of Venous Disease N/A
Completed NCT00005386 - Biobehavioral Determinants of Obesity in Black Women N/A
Completed NCT01205035 - High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia Phase 2
Completed NCT01362192 - Treatment of Lower Extremity Spider Veins With Excel V Phase 4
Completed NCT00725244 - Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias Phase 4
Withdrawn NCT02090517 - Laser Therapy Versus Electrosurgery For Nasal Telangiectasias N/A
Completed NCT02657252 - Polidocanol Versus Glucose Treatment of Telangiectasia Trial Phase 4
Completed NCT02104271 - Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial. Phase 2
Completed NCT00451763 - Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia Phase 3
Recruiting NCT00206921 - Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness N/A